MARKETS
Markets

Jury Awards 10x Genomics Millions in Patent Lawsuit Against Qiagen Unit

Aug 31, 2026 · 01:47 PM ET· updated 55m ago
Jury Awards 10x Genomics Millions in Patent Lawsuit Against Qiagen Unit

10x Genomics won a $4.8 million patent infringement lawsuit against Qiagen subsidiary Parse Biosciences, prompting plans for an injunction.

Share
Why It Matters

A court said 10x Genomics won a dispute because another company copied their invention, and now that company may have to stop selling that product. This shows 10x is protecting its ideas, which can help its business stay strong and different from competitors.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.